cholic acid has been researched along with Fatty Liver, Nonalcoholic in 21 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 12 (57.14) | 24.3611 |
2020's | 9 (42.86) | 2.80 |
Authors | Studies |
---|---|
Chen, J; Fu, Y; He, X; Lan, T; Li, X; Liang, X; Lu, M; Pan, L; Ren, X; Yao, J; Yu, Z | 1 |
Ayala-Zavala, JF; Domínguez-Avila, JA; González-Aguilar, GA; González-Córdova, AF; Ruiz-Canizales, J; Salazar-López, NJ; Vallejo-Córdoba, B; Wall-Medrano, A | 1 |
Alvarez-Parrilla, E; Astiazaran-Garcia, H; de la Rosa, LA; Domínguez-Avila, JA; González-Aguilar, GA; Wall-Medrano, A | 1 |
Chun, HJ; Kwon, YH; Shim, YJ | 1 |
Ao, J; Chiba, T; Fujita, N; Iwanaga, T; Kan, M; Kanayama, K; Kanogawa, N; Kanzaki, H; Kato, J; Kato, N; Kishimoto, T; Kiyono, S; Kobayashi, K; Kojima, R; Kondo, T; Koroki, K; Ma, Y; Muroyama, R; Nakagawa, R; Nakamoto, S; Nakamura, M; Ogasawara, S; Saito, T; Sakuma, T; Unozawa, H | 1 |
Aly, RG; Alzaim, I; El-Mallah, A; El-Yazbi, AF; Shaaban, HH; Wahid, A | 1 |
Chen, M; Gao, X; Guo, H; Huang, Z; Li, X; Lin, X; Xin, Y; Zhu, X | 1 |
Briand, F; Combes, G; Duparc, T; Martinez, LO; Merian, J; Najib, S; Sulpice, T; Trenteseaux, C | 1 |
Asakawa, E; Fukuda, A; Hisano, M; Ichimura, M; Narita, S; Omagari, K; Sasao, M; Suruga, K; Tanaka, K; Tsuneyama, K | 1 |
Chen, CC; Chen, HW; Huang, CS; Kuo, LL; Lii, CK; Lo, CW; Yen, CC | 1 |
Akiyama, N; Fukuhama, N; Hirohata, S; Kitamori, K; Kumazaki, S; Ran, S; Sakai, M; Sato, I; Watanabe, S; Yamamoto, S; Yamori, Y | 1 |
Ali, W; Bush, X; Chen, Q; Chen, Y; Cui, AM; Deng, R; Hashmi, SF; Hurd, Z; Nadolny, C; Qin, G; You, S; Zhang, X | 1 |
Kawaguchi, H; Komohara, Y; Nakagawa, T; Tanimoto, A; Yamada, S; Yoshii, D | 1 |
Guo, X; Hamada, T; Kawaguchi, H; Matsuo, K; Miura, N; Tanimoto, A; Tasaki, T; Yamada, S; Yamada, T | 1 |
Chen, SH; Lee, PF; Lii, CK; Liu, YT; Yao, HT | 1 |
Aronow, B; Dexheimer, PJ; Jha, P; Kirby, M; Kohli, R; Myronovych, A; Ryan, KK; Seeley, RJ; Setchell, KD; Zhang, W | 1 |
Hayashi, Y; Ishii, A; Jia, X; Kaneko, R; Kato, M; Kitamori, K; Naito, H; Nakajima, T; Nomura, M; Suzuki, Y; Yamori, Y; Yetti, H; Zaitsu, K | 1 |
Arab, JP; Arrese, M; Padilla, O; Pizarro, M; Quintero, P; Riquelme, A; Solís, N | 1 |
Barabanchyk, OV; Kozak, NP; Svintsits'kyĭ, AS | 1 |
Bastida, S; Benedí, J; Garcimartín, A; López-Oliva, ME; Merino, P; Sánchez-Muniz, FJ; Santos-López, JA | 1 |
Anzivino, C; Bertolotti, M; Carubbi, F; Carulli, N; Del Puppo, M; Gabbi, C; Loria, P; Losi, L; Macchioni, D; Odoardi, MR; Ricchi, M; Romagnoli, D; Tagliafico, E | 1 |
21 other study(ies) available for cholic acid and Fatty Liver, Nonalcoholic
Article | Year |
---|---|
Sodium cholate ameliorates nonalcoholic steatohepatitis by activation of FXR signaling.
Topics: Animals; Bile Acids and Salts; Cholesterol; Lipids; Mice; Non-alcoholic Fatty Liver Disease; Receptors, Cytoplasmic and Nuclear; Sodium Cholate | 2023 |
Fiber and phenolic compounds contribution to the hepatoprotective effects of mango diets in rats fed high cholesterol/sodium cholate.
Topics: Animals; Antioxidants; Cholesterol, Dietary; Cytoprotection; Diet; Dietary Fiber; Dietary Supplements; Dose-Response Relationship, Drug; Hypercholesterolemia; Lipid Metabolism; Liver; Male; Mangifera; Non-alcoholic Fatty Liver Disease; Phenols; PPAR alpha; Rats; Rats, Wistar; Sodium Cholate | 2019 |
Mango phenolics increase the serum apolipoprotein A1/B ratio in rats fed high cholesterol and sodium cholate diets.
Topics: Animals; Apolipoprotein A-I; Apolipoproteins B; Cholesterol; Humans; Liver; Male; Mangifera; Non-alcoholic Fatty Liver Disease; Phenol; Plant Extracts; Rats; Rats, Wistar; Sodium Cholate | 2019 |
Cholic acid supplementation accelerates the progression of nonalcoholic fatty liver disease to the procarcinogenic state in mice fed a high-fat and high-cholesterol diet.
Topics: Amino Acids; Animals; Carcinogenesis; Carcinoma, Hepatocellular; Cholesterol; Cholesterol, Dietary; Cholic Acid; Diet, High-Fat; Dietary Supplements; Diethylnitrosamine; Disease Progression; Gene Expression Regulation; Lipid Metabolism; Liver; Male; Metabolic Networks and Pathways; Mice; Mice, Inbred C57BL; Mitochondria, Liver; Non-alcoholic Fatty Liver Disease; Transcriptome | 2022 |
A diet-induced murine model for non-alcoholic fatty liver disease with obesity and insulin resistance that rapidly develops steatohepatitis and fibrosis.
Topics: Animals; Cholesterol; Cholic Acid; Diabetes Mellitus, Type 2; Diet, High-Fat; Disease Models, Animal; Fibrosis; Fructose; Insulin Resistance; Liver; Liver Cirrhosis; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Obesity; Triglycerides | 2022 |
Metformin, pioglitazone, dapagliflozin and their combinations ameliorate manifestations associated with NAFLD in rats via anti-inflammatory, anti-fibrotic, anti-oxidant and anti-apoptotic mechanisms.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Benzhydryl Compounds; Biomarkers; Cholesterol; Cholic Acid; Diet, High-Fat; Fibrosis; Glucosides; Inflammation; Insulin Resistance; Liver; Metformin; Non-alcoholic Fatty Liver Disease; Pioglitazone; Rats | 2022 |
Dietary cholesterol drives the development of nonalcoholic steatohepatitis by altering gut microbiota mediated bile acid metabolism in high-fat diet fed mice.
Topics: Animals; Bile Acids and Salts; Cholesterol, Dietary; Cholic Acid; Diet, High-Fat; Gastrointestinal Microbiome; Hypercholesterolemia; Liver; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease | 2023 |
Liraglutide improves hepatic steatosis and metabolic dysfunctions in a 3-week dietary mouse model of nonalcoholic steatohepatitis.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Cholesterol, Dietary; Cholic Acid; Diet; Diet, High-Fat; Hypoglycemic Agents; Insulin Resistance; Lipid Metabolism; Liraglutide; Liver; Liver Cirrhosis; Metabolic Diseases; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease | 2019 |
Dietary fat, cholesterol, and cholic acid affect the histopathologic severity of nonalcoholic steatohepatitis in Sprague-Dawley rats.
Topics: Animals; Cholesterol, Dietary; Cholic Acid; Dietary Fats; Disease Models, Animal; Liver Cirrhosis; Liver Cirrhosis, Experimental; Non-alcoholic Fatty Liver Disease; Rats; Rats, Sprague-Dawley | 2019 |
Benzyl isothiocyanate ameliorates high-fat/cholesterol/cholic acid diet-induced nonalcoholic steatohepatitis through inhibiting cholesterol crystal-activated NLRP3 inflammasome in Kupffer cells.
Topics: Animals; Cholesterol; Cholesterol, Dietary; Cholic Acid; Diet, High-Fat; Dose-Response Relationship, Drug; Inflammasomes; Interleukin-1beta; Isothiocyanates; Kupffer Cells; Lipid Metabolism; Liver; Liver Function Tests; Male; Mice; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Non-alcoholic Fatty Liver Disease; Triglycerides | 2020 |
Bile acids aggravate nonalcoholic steatohepatitis and cardiovascular disease in SHRSP5/Dmcr rat model.
Topics: Animals; Aorta; Bile Acids and Salts; Cardiovascular Diseases; Cholic Acid; Diet, High-Fat; Gene Expression Regulation; Humans; Lipid Metabolism; NF-kappa B; NG-Nitroarginine Methyl Ester; Non-alcoholic Fatty Liver Disease; Rats; Vascular Cell Adhesion Molecule-1 | 2020 |
Dysregulation of bile acids increases the risk for preterm birth in pregnant women.
Topics: Adolescent; Adult; Animals; Bile Acids and Salts; Carbon Tetrachloride; Cholic Acid; Disease Models, Animal; Female; Hospitals; Humans; Infant, Newborn; Liver Diseases; Male; Mice; Middle Aged; Non-alcoholic Fatty Liver Disease; Pregnancy; Pregnancy Outcome; Pregnancy, Animal; Premature Birth; Prospective Studies; Signal Transduction; Young Adult | 2020 |
Phenotypic Changes in Macrophage Activation in a Model of Nonalcoholic Fatty Liver Disease using Microminipigs.
Topics: Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Cholesterol; Cholic Acid; Diet, High-Fat; Disease Models, Animal; Disease Progression; Hepatic Stellate Cells; Lymphocytes; Macrophage Activation; Macrophages; Non-alcoholic Fatty Liver Disease; Phenotype; Receptors, Cell Surface; Swine; Swine, Miniature | 2021 |
Cholic Acid Enhances Visceral Adiposity, Atherosclerosis and Nonalcoholic Fatty Liver Disease in Microminipigs.
Topics: Adiposity; Animals; Atherosclerosis; Cholic Acid; Diet, High-Fat; Disease Models, Animal; Male; Non-alcoholic Fatty Liver Disease; Obesity, Abdominal; Swine; Swine, Miniature | 2017 |
Freshwater clam extract reduces liver injury by lowering cholesterol accumulation, improving dysregulated cholesterol synthesis and alleviating inflammation in high-fat, high-cholesterol and cholic acid diet-induced steatohepatitis in mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Biological Products; Biomarkers; Cholesterol, Dietary; Cholic Acid; Corbicula; Diet, High-Fat; Dietary Fats, Unsaturated; Dietary Supplements; Female; Lipid Metabolism; Lipotropic Agents; Liver; Mice, Inbred C57BL; Muscles; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Random Allocation; Shellfish; Tissue Extracts | 2018 |
Vertical sleeve gastrectomy reduces hepatic steatosis while increasing serum bile acids in a weight-loss-independent manner.
Topics: Animals; Bile Acids and Salts; Caloric Restriction; Cholic Acid; Diet, High-Fat; Down-Regulation; Fatty Liver; Gastroplasty; Gene Expression Profiling; Gene Expression Regulation; Lipogenesis; Liver; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Obesity; Postprandial Period; Random Allocation; Taurochenodeoxycholic Acid; Triglycerides; Up-Regulation; Weight Loss | 2014 |
A possible role of chenodeoxycholic acid and glycine-conjugated bile acids in fibrotic steatohepatitis in a dietary rat model.
Topics: Animals; Biomarkers; Chenodeoxycholic Acid; Cholic Acid; Chromatography, Liquid; Deoxycholic Acid; Diet, High-Fat; Fatty Liver; Liver; Liver Cirrhosis; Male; Non-alcoholic Fatty Liver Disease; Random Allocation; Rats; Tandem Mass Spectrometry | 2014 |
Bile acid supplementation improves established liver steatosis in obese mice independently of glucagon-like peptide-1 secretion.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cholesterol 7-alpha-Hydroxylase; Cholic Acid; Gene Expression; Glucagon-Like Peptide 1; Glucose Tolerance Test; Incretins; Liver; Male; Mice; Mice, Obese; Non-alcoholic Fatty Liver Disease; Organic Anion Transporters, Sodium-Dependent; Receptors, Cytoplasmic and Nuclear; Symporters; Triglycerides; Ursodeoxycholic Acid | 2014 |
[CORRECTION OF BILE FLOW CHARACTERISTICS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE IN COMBINATION WITH HYPERURICEMIA].
Topics: Adult; Allopurinol; Bile; Cholagogues and Choleretics; Cholestasis, Intrahepatic; Cholesterol; Cholic Acid; Deoxycholic Acid; Drug Therapy, Combination; Duodenoscopy; Female; Fluorobenzenes; Humans; Hyperuricemia; Liver; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Taurocholic Acid; Uric Acid; Ursodeoxycholic Acid | 2014 |
Effects of Silicon vs. Hydroxytyrosol-Enriched Restructured Pork on Liver Oxidation Status of Aged Rats Fed High-Saturated/High-Cholesterol Diets.
Topics: Aging; Animal Feed; Animals; Antioxidants; Body Weight; Catalase; Cholesterol, Dietary; Cholic Acid; Colloids; Dietary Fats; Drug Evaluation, Preclinical; Fatty Acids; Glutathione; Hypolipidemic Agents; Liver; Male; Meat; NF-E2-Related Factor 2; Non-alcoholic Fatty Liver Disease; Oxidation-Reduction; Phenylethyl Alcohol; Rats; Rats, Wistar; Silicon Dioxide; Superoxide Dismutase; Sus scrofa; Swine | 2016 |
Effects of bile duct ligation and cholic acid treatment on fatty liver in two rat models of non-alcoholic fatty liver disease.
Topics: Animals; Biomarkers; Cholesterol 7-alpha-Hydroxylase; Cholic Acid; Common Bile Duct; Diet, High-Fat; Dietary Supplements; Disease Models, Animal; Fatty Liver; Gas Chromatography-Mass Spectrometry; Hydroxycholesterols; Ligation; Liver; Liver X Receptors; Male; Non-alcoholic Fatty Liver Disease; Orphan Nuclear Receptors; Random Allocation; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Receptors, Cytoplasmic and Nuclear; Treatment Outcome | 2012 |